Skip to content
Medical Health Aged Care

Brisbane comes together for people impacted by dementia

Dementia Australia 2 mins read

Brisbane community members tied up their laces and showed up in force last weekend for the 2026 Brisbane Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health.

 

More than 1,470 people walked, ran and jogged to the finish line to raise an impressive total of $195,098.

 

Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause.

 

“There was an incredible turnout from the Brisbane community this year yet again, in support of the many people impacted by dementia across the country,” Professor Buchanan said.

 

“It’s been really moving and encouraging to see the community supporting Dementia Australia’s vital work by raising funds and awareness, as well as moving for their brain health - which research shows can help reduce our risk of dementia.”

 

Professor Buchanan also acknowledged everyone who volunteered at the Brisbane Memory Walk & Jog. 

 

“The day was only possible through the hard work of our wonderful volunteers, who always make Memory Walk & Jog a safe, fun and memorable experience for everyone who takes part”.

 

This event was one of 14 Memory Walk & Jog events held across Australia in 2026. Each event offers a wonderful opportunity for people impacted by dementia and their supporters to come together, walk or run, at any fitness level, and to raise money and share stories.

  

Missed this event but want to be involved? Organise your own group or individual walk or jog, with a MyWay event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw. 

 

-Ends-

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 446,500 Australians living with dementia, and the more than 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Teresa Cong, Senior Media & Communications Advisor, [email protected], 0423 383 564

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

Photos and video of previous Memory Walk & Jog events for publication are available for use.

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 17/06/2026
  • 06:15
Monash University

New Guiding Principles to improve incontinence medication safety for people living with dementia

Monash University researchers are today launching the first co-designed resources to safely guide the use of urinary incontinence medications for people living with dementia. Doctors routinely prescribe medications to manage urinary incontinence, but the medications can carry hidden dangers for people with dementia, increasing the risk of side effects such as worsening memory loss. Despite the risks, the healthcare sector previously lacked evidence-based co-designed resources to help families and healthcare professionals decide when to start or stop treatment. Dr Amanda Cross, who developed the 10 Guiding Principles with her team from the Centre for Medicine Use and Safety at the…

  • Medical Health Aged Care
  • 16/06/2026
  • 22:47
Optimi Health Corp.

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studiesNew microdose formats extend Optimi's psilocybin range, which includes a 5mg formulation currently commercially prescribed for treatment-resistant depression in Australia under the country's Authorized Prescriber SchemeVANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, today announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and 2 mg dosages. The products…

  • Biotechnology, Medical Health Aged Care
  • 16/06/2026
  • 09:51
ENA Respiratory

ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations

Melbourne, Australia, 15 June 2026 – ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for two patent applications notably a composition-of-matter patent and method-of-use for its Toll-like receptor 2 (TLR2) therapies. A composition-of-matter patent (US 17/622,451, "A series of TLR2 agonist compounds") and A method-of-use patent for the treatment of rhinovirus-mediated exacerbations of chronic obstructive pulmonary disease (COPD) (US 16/495,829, "Methods of treating rhinovirus-mediated exacerbations of COPD…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.